Prognostic value of 18F-FDG PET and PET/CT for assessment of treatment response to neoadjuvant chemotherapy in breast cancer: a systematic review and meta-analysis.

Published in: Breast cancer research : BCR (2020)

The currently available literature suggests that the use of 18F-FDG PET or PET/CT for evaluation of response to NAC provides significant predictive value for disease recurrence and survival in breast cancer patients and might allow risk stratification and guide rational management.

Keyphrases

pet ct
neoadjuvant chemotherapy
locally advanced
positron emission tomography
free survival
lymph node
sentinel lymph node
systematic review
squamous cell carcinoma
rectal cancer
radiation therapy
clinical evaluation
childhood cancer